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Abstract
Background: The Human Papillomavirus (HPV) is a significant factor associated with the
development of HPV-associated cancers in the United States. The administration of the HPV
vaccination is a critical prevention strategy in reducing HPV-related cancers in the United States.
The state of Kentucky has lower than average HPV vaccination rates compared to the national
average. There is a significant amount of evidence exploring barriers and facilitators of the HPV
vaccination administration. There are several multi-level barriers associated with low uptake of
the HPV vaccination in adolescents. Multiple sources of evidence have indicated that parents
who receive a provider recommendation are much more likely to receive the HPV vaccination.
Purpose: The purpose of this project is to assess the effectiveness of an educational intervention
on health care provider’s understanding of the importance of their own vaccine recommendations
to adolescent families to improve HPV vaccination rates.
Methods: This is a quasi-experimental pretest–posttest design. The sample includes medical
providers and clinical staff of the University of Kentucky Adolescent Medicine Clinic.
Participants completed a pre-survey, an educational quality improvement (QI) session, and postsurvey derived from an evidence-based HPV IQ toolkit from the University of North Carolina
Gillings School of Public Health. Likert scales were used to analyze provider and clinic staff
attitudes before and after the session, perceived importance of components of the session, and to
evaluate the change in provider attitudes before and after the session. A paired t-test was used to
compare provider attitudes before and after the QI session. Clinic HPV immunization rates of
13-year-old males and females were collected from the Kentucky Immunization Registry before
the project implementation and three months following the QI session.

Results: A total of 13 participants completed the pre-survey and the QI education session in
November of 2020. A total of 11 participants completed the post-survey. During the post-survey,
participants completed an evaluation of the QI program, which demonstrated overall positive
attitudes of providers and clinic staff surrounding the HPV vaccination before the session and
improved attitudes after the session. In the three months following the educational intervention,
completion of at least one HPV vaccination documented improved from 81% to 86% of UK
Adolescent Medicine 13-year-old patients.
Conclusion: A gap exists between national recommendations and HPV vaccination completion
rates in adolescents due to multiple factors in the United States. Following a QI session,
improvement was observed of 13-year-old male and females HPV rates and strength of attitudes
of medical staff strength within UK Adolescent Medicine. Although results lacked statistical
significance, this study highlights an individual clinic’s ability to obtain tools necessary to set
goals, implement evidence-based practices, and improve patient outcomes. Further large
participant multi-level evidence-based interventions are recommended.
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Background and Significance
The Human Papillomavirus (HPV) is a significant factor in the development of cervical
cancer, contributing to approximately 31,500 HPV-associated cancers in men and women in the
U.S. each year (CDC, 2018). HPV is linked to 90% of cervical and anal cancers, 60% of penile
cancers, and 70% of vaginal, vulvar, and oropharynx cancers (CDC, 2018). Cervical cancer is
the second leading cause of cancer in women worldwide, and the most common HPV-associated
cancer in the female population (CDC, 2018). There have been several public health
interventions to mitigate the impact of cervical cancer, including a primary prevention strategy:
vaccination. The United States has had access to a vaccination to protect the population from
HPV-related cancers since 2006, but it is one of the most under-utilized vaccines recommended
by the Centers for Disease Control’s Advisory Committee on Immunization Practices (ACIP).
The ACIP recommends that middle school students receive one HPV vaccination with their
scheduled 11-year-old immunizations and another vaccination after 6 months of the first
vaccination. According to Walker et al. (2017), far fewer U.S. adolescents receive the CDCrecommended HPV vaccine than other vaccines mandated by individual states. Approximately
88% of children entering 6th grade receive the Tdap booster that is required for school entrance;
in contrast, only 56-65% of adolescents receive a single dose of the HPV vaccination, with only
43.4% completing the HPV series (Walker et al., 2017).
There is limited transparency concerning HPV immunization rates as compared to other
childhood immunizations. The CDC publishes immunization rates from each school to create
accurate immunization reports by region. Although the HPV vaccination is recommended by the
ACIP, the completion of the 2-dose vaccination series is not mandatory for school entry in
Kentucky. HPV vaccination data are not reported to the state annually from school systems; they
9

are only reported through annual phone interviews administered by the CDC. Consequently,
nationally collected data does not reflect community level HPV rates. Rates of the HPV
vaccinations are unable to be visualized at a community level, leading to difficulty in improving
focused improvement processes. According to a CDC NIS-Teen survey of approximately 300
adolescents in 2017, Kentucky’s effort at increasing HPV vaccination rates has been poorer than
the nation’s average (Walker et al., 2017). Of children in Kentucky between the ages of 13-17,
only 37.7% (US: 49%) have completed the HPV vaccination series and only 49.6% (US: 65.5%)
had coverage with at least one dose of the vaccination (Walker et al., 2017). The NIS-teen
survey assesses multiple demographic characteristics to predict the status of whether a HPV
vaccination was completed including: sex, mother’s education level, whether they’ve had an 11
or 12 year old annual exam, a provider recommendation of the HPV vaccination, and guardian’s
intent to receive an HPV shot in the next 12 months. Analysis of CDC data observed that one of
the most important factors associated with adolescents receiving the HPV vaccination was
receiving a recommendation from their provider (Rahman et al., 2015). In addition to
improving provider’s ability to recommend the vaccination, evidence suggests that multi-level
strategies that are sensitive to the needs of patients, providers, organizations, and systems assist
in improving HPV initiation and completion rates (Lu et al., 2019; Dilley et al., 2018; Carhart et
al., 2018).
Data must be transparent for systems to methodically develop goals and improve
outcomes. In the last decade, several states have supported the creation of electronic
immunization registries to accurately store health information that can be easily accessible to
primary care offices. The Kentucky Immunization Registry (KYIR) is a computer-based
repository and tracking system which was implemented by the Kentucky Department of Public
10

Health (KYIR, 2020). This program was initiated in 2009 and data is growing over time on
adolescent vaccinations. This system provides for the sharing of immunization information
among authorized users, though it is not mandated that medical facilities administering
vaccinations record data into the registry; therefore, this online portal harbors incomplete records
of vaccination administration that could be used for tracking purposes. Public health initiatives
are often complex and require multiple levels of intervention to improve long-term outcomes.
This project will help fill the knowledge gaps around known barriers associated with low HPV
rates in Kentucky adolescents.
Purpose
The purpose of this project is to assess the effectiveness of an educational intervention on
health care provider’s understanding of the importance of their own vaccine recommendations to
adolescent families to improve HPV vaccination rates. The four aims of this project included:
1. To provide education for UK Adolescent Medicine Clinic medical providers and
clinical staff with a virtual HPV Quality Improvement Session through use of evidence-based
HPV IQ quality improvement tools.
2. To analyze provider and staff confidence and attitudes surrounding HPV vaccination
practices before and after a quality improvement session.
3. To compare Kentucky Immunization Registry data of 13-year-old male and female UK
Adolescent Medicine patients with one valid HPV vaccination on 11/9/2020 and 2/9/2021.
4. To evaluate medical provider and clinical staff evaluations of the QI program.
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Conceptual Framework
The theory of planned behavior (TPB) guided this project. The theory states that behavior
modification depends on an individual’s motivation and abilities. TPB can be used during the
implementation of process changes to achieve positive outcomes (Batista et al., 2015). The
planned behavior defined in this project is a provider recommending the HPV vaccination. The
theory explains that three general constructs which guide human behavior. The first construct
includes is the attitude of the behavior, and whether one thinks this particular behavior makes
sense for them. The second construct is the subjective norm. This includes everything around
the individual such as cultural or group beliefs. The third construct is perceived behavioral
control, which expresses how easy how hard it is to display a behavior or act a certain way. The
theory of planned behavior forecasts that a positive attitude the behavior, a favorable social
norm, and a high level of perceived behavioral control are the best predictors for forming a
behavioral intention which lead to a displayed behavior. In short, if individuals think a behavior
is a good idea, everyone else thinks it is a good idea, and it can be carried out successfully, then
the intention will exist for a behavior to be carried out. However, if one construct is unfavorable,
then one is less likely to behave in the planned way. Behavioral beliefs tend to produce a
favorable or unfavorable attitude toward a behavior and guide the consideration of positive and
negative outcomes. Each of these beliefs influences the intention of an individual before making
a new decision. Each defined aim can be associated with TPB.
Historically, immunizations have been developed to mitigate the impact of lifethreatening medical illnesses. The HPV vaccination was one of the first immunizations to
address a chronic health issue: cancer. The HPV vaccination was presented to the healthcare
market in 2006 making it the newest CDC-ACIP recommendation, and one of the only
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vaccinations that is not mandatory for school entry. A common clinic scenario can help explain
the TPB. A parent brings a child in for mandated vaccinations because they received a letter
from the school notifying them of due vaccinations before school entry. If the parent presents to
a clinic asking their child to receive the list of necessary vaccinations that do not include the
HPV vaccination (parental subjective norm construct), a provider will choose to recommend the
HPV vaccination in addition to what a parent may request (provider attitude of the behavior). In
this situation, a provider may or may not decide to ask a parent to accept the HPV vaccination in
addition to other vaccines. Before carrying out the behavior, a provider may be concerned with
the positive or negative consequences that may come from having a conflict with a family
member if they are vaccine-hesitant (provider attitude of behavior). In this situation, a parent
may respond that they don’t want their child to receive the vaccination. A provider may be
concerned about whether they have the tools, confidence, and knowledge to carry out the new
behavior (perceived behavioral control).
The intervention within this project provides dialogue and approaches to carry out the
behavior. Aim 1 seeks to give providers the communication tools to have conversations with
family members. Aim 2 will aid in recognizing general beliefs and attitudes and establishing a
subjective provider norm surrounding the HPV vaccination in the Adolescent Medicine Clinic.
Aim 3 will evaluate the efficacy of the intervention and an example of a tool to utilize which can
influence provider perceived behavioral controls. Aim 4 will provide data to the primary
investigator of the study on perceived behavioral control. The three attitudes of the TPB
formulate a person’s intention before executing a behavior change. When there are varying
levels of social acceptability of a behavior, the TPB may be utilized to target several types of
barriers associated with lack of change towards a positive health behavior (Batista et al, 2015).
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The theory of planned behavior was utilized throughout this project to provide medical staff with
the appropriate knowledge, understanding, confidence, and tools needed to carry out successful
implementation. The literature review provides multiple examples of TPB constructs which
influence provider behaviors.
Review of Literature
The purpose of this literature review was to explore health care provider barriers
associated with recommending the HPV vaccine to adolescents. An electronic search was
conducted using the databases Medline, PubMed, CINAHL, and Web of Science. The initial
search of evidence resulted in approximately 79 peer-reviewed articles, of which 20 met inclusion
criteria. These criteria included peer-reviewed publication in English between 2009 and 2019.
Search terms: human papillomavirus, adolescents, vaccination, vaccine, barriers, provider
barriers, provider perceptions, recommendations.
The review of evidence revealed several examples of provider-perceived barriers to
recommending the HPV vaccination. Providers are considered individuals who is licensed to
practice and bill for services, such as a physician, physician assistant, or nurse practitioner. There
are various obstacles cited in the literature at the parent-child, interpersonal, community and
policy levels, contributing to poor uptake of HPV vaccination (Carhart et al., 2018). Several
studies found that interventions that improve clinician attitudes may reduce missed opportunities
of administering the HPV vaccine (Rosen et al., 2018; Cunningham-Erves et al., 2019; Dilley et
al., 2018). Providers in private practice areas reported barriers associated with vaccine ordering,
stocking costs, reimbursements, and insurance coverage compared to those in public settings.
Offices accepting public insurances receive HPV vaccination stock through federally funded
programs. Many private offices elect to not purchase HPV vaccination stock due to concern of
14

expiration and lost revenue if parents refuse the vaccination. Perceived provider barriers
regardless of a public or private setting included perceived parental concerns about safety, age of
the child, low risk of infection of the child through sexual activity, and mistrust in vaccinations
(Cunningham-Erves et al., 2019). These provider perceived parental HPV hesitancies were
associated with provider self-efficacy, outcome expectations, and confidence in HPV safety
(Cunningham-Erves et al., 2019). System barriers reported by providers included the nature of
the HPV dosing schedule, poor tracking systems, and lack of school-based vaccination
requirements (Tom et al., 2016; Dilley et al., 2018).
Providers acknowledge that there is no single reason a parent refuses to vaccinate their
child with the HPV immunization (Garbutt et al., 2018). One evidence-based strategy positively
influencing a parent’s decision to vaccinate the HPV vaccination is motivational interviewing.
This interviewing technique improves provider’s communication with parents who are HPV
vaccine-hesitant (Reno et al., 2018). Motivational interviewing is a guiding style of
communication, which utilizes methods such as “change talk” to reinforce intrinsic motivation in
individuals (Garbutt et al., 2018). There is minimal research relating to motivational interviewing
and increasing HPV vaccination rates (Reno et al., 2018). Much of the research surrounding
motivational interviewing has assessed its impact on adult populations. In addition to specified
techniques, several studies supported education and skill-building communication of providers
and families to increase HPV vaccination rates (Lake et al., 2019; Tom et al., 2018). Training
tailored to address barriers in specific regions helps improve HPV vaccine rates (Javaid et al.,
2017; Holeman et al., 2014; Dilley et al., 2018). Providers desire training on how to discuss
individual concerns with parents about the HPV vaccination (Fleming et al., 2018). Providers
prefer facility-based and web-based training methods (Fleming et al., 2018; Kumar et al., 2019).
15

Although it is apparent that a provider recommendation is a critical factor in HPV vaccine
completion for adolescents, multi-level strategies, such as standing orders, provider reminders,
clinic flow alterations, and system-level interventions would be effective in allowing providers
the support for vaccine recommendation (Lu et al., 2019).
The literature reviewed suggests several gaps contributing to the reduced frequency of
providers recommending the HPV vaccination. Training methods are needed to address
concerns of providers regarding communication (Reno et al., 2018). Healthcare systems could
provide support to medical staff to eliminate barriers to recommending the HPV vaccination
(Eddens et al., 2017). Approaches such as borrowing quality improvement programs and
strategic planning practices are informing thoughtful process changes within institutions
(Wilburn et al., 2016). A more thorough investigation on training methods and their efficacy
would help support medical providers’ need for communication skills (Reno et al., 2018, Gilkey
et al., 2016).
Methods
Design
The study design is a quasi-experimental pretest–posttest design that did not include a
control group. The pre-survey, post-survey, and vaccination data were entered into the SPSS
statistical program for analysis. Internal data were collected and a paired t-test was used to test
for differences in the data set. The data collected for this study were then analyzed by using
descriptive statistics through SPSS software.
Setting
The setting for this study was the University of Kentucky Department of Pediatrics,
Division of Adolescent Medicine. The population of this survey included the provider and clinic
16

staff at the University of Kentucky Department of Pediatrics, Division of Adolescent Medicine,
and adolescents thirteen years of age with an active Kentucky Immunization Registry. The
providers that make up this primary care clinic include four physicians, three nurse practitioners,
and one physician assistant. Clinic staff includes nurses, medical assistants, and patient care
technicians. The primary population served in the UK Adolescent Medicine Clinic are
adolescents aged 10-25 from the Central Kentucky area. Since May of 2020, the clinic has
provided approximately 50% telemedicine visits and 50% in-person medical visits. The
Adolescent Medicine Clinic is considered a primary care clinic and adolescent specialty clinic
and serves approximately 4,000 urban and rural adolescents annually. In the University of
Kentucky Department of Pediatrics, there are no standardized methods in which clinic staff can
visualize initiation of one or series completion rates of the HPV vaccination.
DNP Project Congruence
The University of Kentucky Healthcare system includes inpatient and outpatient services.
The University of Kentucky’s Chandler Medical Center is an Academic Level 1 Trauma Center.
The University of Kentucky, Department of Pediatrics, Division of Adolescent Medicine is a
research facility and clinical site providing primary and specialty care to a diverse group of
patients on an outpatient basis. UK HealthCare has five DIReCT values to aid in actions,
behaviors, and decision-making within the work environment. These include: diversity,
innovation, respect, compassion, and teamwork. UK HealthCare is committed to academic
health care – research, education, and clinical care. UK Healthcare’s vision is to achieve
national recognition as a Top 20 public academic health center and provide advanced and
multidisciplinary health care to Kentucky and surrounding areas.
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Description of Stakeholders
There are a variety of stakeholders found within this project setting. These include The
Division of Adolescent Medicine, The Department of Pediatrics at the University of Kentucky,
and UNC Gillings School of Public Health. The Division of Adolescent Medicine is the physical
clinic where the study was conducted. Its location is at the Kentucky Clinic, an ambulatory
setting within the University of Kentucky. It is a division of the Department of Pediatrics. The
University of Kentucky’s Department of Pediatrics has been providing service and education
through the University of Kentucky (UK) College of Medicine since 1961. UK’s College of
Medicine’s most recent strategic plan is divided into five pillars. These pillars include Clinical
Care, Education, Community Engagement, Diversity and Inclusivity, and Research. UNC
Gillings School of Global Public Health is an entity offering publically HPV quality
improvement tools without permission. These established tools were utilized to implement a
quality improvement session at UK Adolescent Medicine through the HPV IQ materials and
methods. These materials were tested in the field with seven state health departments. There
was funding provided by the Robert Wood Johnson Foundation for the HPVIQ website and the
Assessment and Feedback Tools research.
Facilitators and Barriers of Implementation
Academic sites are often open and receptive to evidence-based trainings and research
collection, which was a facilitator of project implementation. Collaborating with site leadership
representatives to coordinate and reserve time to deliver education and allow feedback was a
barrier. It was necessary to schedule activities well in advance to ensure providers and staff were
be the ability to attend sessions.
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Sample
A. Adolescent Medicine Clinic Providers and Staff: The population selected was medical
and clinical staff from the UK Adolescent Medicine Clinic in Lexington, KY. The
sample of this study included medical providers (MD, DO, NP, PA) and clinical staff
(registered nurses and certified medical assistants) at the University of Kentucky
Department of Pediatrics, Division of Adolescent Medicine. Inclusion criteria were all
part-time or full-time medical providers and clinic staff assigned to the Division of
Adolescent Medicine. Exclusion criteria: professional students assigned to any medical
providers
B. Patient population: A sample of adolescents was collected from UK Adolescent Medicine
Clinic. These data did not include any identifiable patient information. The de-identified
data were extracted by a representative from the Kentucky Immunization Registry team.
Inclusion criteria: Male or female aged 13 with an active status in the Kentucky
Immunization Registry.
Procedure
This project was approved by the IRB on October 20, 2020. IRB Approval #62686 was
entitled "Improving Human Papillomavirus Vaccination Uptake among Kentucky Adolescents
through Provider Education.” Open source tools were used from the University of North
Carolina (UNC) School of Public Health for this project. The HPV IQ Assessment and
Feedback Toolkit’s goal is to raise HPV vaccination coverage across the United States. The
toolkit provided several resources that are of no cost to users and publicly available, including
standardized scripts and evaluation tools (Brewer et al., 2020). The toolkit provides a
standardized approach to address vaccine hesitant parents with the “Announcement Approach
19

Training.” Tools educate providers on presumptive announcement approaches and
communication techniques to address common parental concerns. The HPV IQ Protocol was
developed with the CDC and many state health departments and designed to complement the
CDC’s AFIX model and existing state health department plans in Arizona, Illinois, Michigan,
New York, North Carolina, Washington State, and Wisconsin (Brewer et al., 2020). Providereducation tools which have recently been developed have not been externally validated.
According the UNC School of Public Health representatives, since 2016, this training method
has been provided to approximately 1375 healthcare workers. In addition, the National Cancer
Institute designated it as a Research-Tested Intervention Program, and the CDC and American
Academy of Pediatrics endorses use of presumptive announcements when recommending HPV
vaccine. I was personally trained in a session hosted by the University of North Carolina Public
Health Program Announcement Approach during a California HPV Roundtable Train-theTrainer Event.’ These tools include:
1. Pre-survey: evaluated providers’ beliefs and practices about HPV vaccination before
the 60-minute virtual quality improvement (QI) session
2. Training session script for educational quality improvement session
3. Training slides to present material from training script
4. The announcement approach handout exercise
5. Post-survey: measured providers’ beliefs and practices about HPV vaccination,
perceived importance of components of the QI session, and evaluation of satisfaction of
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the QI program directly following the quality improvement session for comparison to the
results of the pre-survey.
The Quality Improvement training session was completed through a scheduled 60-minute
virtual session during a scheduled staff meeting with UK Adolescent Medicine medical providers
and nursing clinical staff. Pre and post-surveys were collected and analyzed to evaluate changes
in provider perceived confidence and attitudes in quality improvement activities and improving
HPV vaccination rates. Fifteen minutes were allotted for each of the surveys to be administered
before and after the quality improvement session.
The HPV IQ toolkit encourages practices to utilize state immunization information
systems (IIS) to collect data on clinic vaccination rates. Kentucky’s system is the Kentucky
Immunization Registry (KYIR). Each clinic in Kentucky has an identifier number to determine
the physical location of immunization administered. HPV vaccination rates were collected on
thirteen-year-old males and females assigned to the University of Kentucky Adolescent
Medicine Clinic who have had at least one vaccination documented in the KYIR. The
Adolescent Medicine Clinic Kentucky Immunization Registry identification number was used to
collect HPV immunization rates by a third-party representative. This vaccination data were
measured before and three months post-intervention to compare HPV rates. All quantitative data
were analyzed using descriptive statistics. Procedure steps included:
1. The Division of Adolescent Medicine within the Department of Pediatrics of the
University of Kentucky provided a letter of support.
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2. The Division Chief, Practice Manager, and Nursing Leader of the Division of
Adolescent Medicine was contacted via e-mail to schedule the administration of the pre-survey,
quality improvement session, and post-survey to medical providers and nursing clinical staff.
The Quality Improvement Session was offered virtually through a Zoom meeting after the
completion of patient care activities of the day. The title of the 60-minute virtual training was
“Making Effective HPV Vaccination Recommendations,” from the HPV IQ Toolkit.
3. The PI sent an email to all potential clinic provider subjects explaining the project and
requesting their participation. Participation in the study was completely voluntary. Completion of
the survey served as consent. Participants could skip any question on the survey.
4. Participants completed a pre-and post-survey which included defined demographics
and participant attitudes surrounding the HPV vaccination.
5. A pre-survey was administered to those who volunteered for the study through a URL
that was located on the screen via a QR code directly before the start of the quality improvement
session. The quality improvement session was completed with a training script and training
presentation through the HPV IQ tool kit. A post-survey was administered following the training
session through the URL that was given to each participant at the beginning of the session.
6. The education was guided by the processes outlined in the HPV IQ Toolkit
Measures
The assessments participants completed were derived from the HPV IQ Toolkit. The presurvey included demographic information related to role, years of experience, sex, and ethnicity
(table 1). In the pre-survey participants indicated which HPV vaccination strategies they were
22

utilizing prior to intervention (table 6). Attitudes were measured on a 5-point Likert scale from
strongly disagree, somewhat disagree, neutral, somewhat agree to strongly agree (table 2). The
pre and post survey assessed elements of provider intention, self-efficacy, and norms. Each
participant evaluated the quality improvement and session on the same scale as the attitudes
Likert scale (table 4). Participant perceptions regarding importance were measured from not
important (1) to extremely important (5) (table 5).

Survey data from providers (medical

providers and clinical staff) were submitted electronically through REDCap, a secure web
application utilized for capturing data for research studies. Data Analysis Statistical Package for
the Social Sciences (SPSS) software was utilized in the compilation and analysis of the data that
were reported. All data were secured electronically behind the University of Kentucky computer
firewall on the PIs password-protected, encrypted, computer. Data practices were followed
according to the University of Kentucky’s policy, A13-050. A third-party representative from
the Kentucky Immunization Registry abstracted aggregate data. No patient identifiers other than
age and clinic location were available on this report.
Descriptive statistics including frequency distributions or means and standard deviations
were used to summarize study variables. The paired t-test was used to determine the difference
in the pre-intervention and post-intervention attitude questions and total summative score. The
chi-square test of association was used to determine differences in registry data of vaccination
rates between the two time periods. All data analysis was conducted using SPSS, version 25,
with an alpha of .05 throughout.
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Results
Sample Demographics
A total of 13 participants (table 1) completed the pre-survey, and a total of 11 participants
completed the post-survey. Of these participants, 84% were Caucasian and 100% were female.
There was a variety of different roles within this study; 31% of the participants were Registered
Nurses, 23% were Nurse Practitioners, 23% were Physicians, 15% were Clinical Service
Technicians, and 7% were Physician Assistants. Years of experience ranged from less than 5
years to greater than 20 years. Approximately 39% of participants had fewer than 5 years of
experience, 31% had 5-9 years of experience, 15% had 10-14 years of experience, and 15% had
greater than 15 years of experience. The pre-survey indicated that 77% of participants
encouraged providers to routinely recommend HPV vaccine to age-eligible patients and provided
educational materials on HPV vaccination to parents and patients.
The pre-survey post-survey Likert scale ranged from strongly disagree (1) to strongly
agree (5). “Improving HPV vaccination coverage is an important goal for my practice or clinic”
mean increased from 4.54 to 4.91. “Confidence in practice being able to improve HPV
vaccination coverage” increased from 4.62 to 4.73. “Confidence in personally being able to
improve HPV vaccination coverage” mean had the greatest attitude change from 4.08 to 4.80,
which was a statistically significant finding. “HPV vaccination coverage in my practice or clinic
is lower than I’d like it to be” negatively changed from 2.85 to 2.27. At the time of the QI
session, participants gained the knowledge that rates within this clinic are higher than national
and state averages. This likely corresponds to the neutrality of the pre-survey and reduced mean
of the post-survey of this attitude. Overall, all attitudes means surrounding the HPV vaccination
improved from 16.3 to 16.8 after the QI session with low statistical significance.
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The evaluation Likert scale was identical to the attitudes assessment. Participants
responded between somewhat agree to strongly agree that the session was convenient, the
facilitator was knowledgeable, the content was understandable, and the session would help their
clinic to improve HPV coverage. Participants measured important components of the QI session
on the Likert scale of not important (1) to very important (5). Data demonstrated that all
providers believed all four components were very important to extremely important. Providers
and clinic staff demonstrated that the most important components of the quality improvement
session were discussing provider recommendation significance and committing to quality
improvement strategies to increase vaccination coverage.
In this study, participants were able to provide quantitative and qualitative suggestions
for improving the training program that begins to remedy this lack of evidence. One participant
suggested that the facilitator “give updated male related cancer prevention stats to use. Parents
respond well to numbers, and I know the numbers for cervical cancer reduction, but not penile
and anal. Also didn't know about the throat cancers so more on that. Thanks!”
Registry data (table 7) were collected by a third party from the Kentucky Immunization
Registry found that 13-year-old vaccination rates improved between November of 2020 to
February of 2021. The sample size of 13-year-old male and female in November 2020 was 127
patients, and in February was 118 patients with an active registry within the UK Adolescent
Medicine Clinic. Registry data found that approximately 81% of 13-year-old male and females
had at least one HPV vaccination administered in November of 2020, and 86% had at least one
HPV vaccination administered in February of 2021. Data from both period exhibited an equal
distribution of one HPV dose administered of male and female patients.
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Discussion
The focus of this study was to analyze provider and clinic staff attitudes surrounding the
HPV vaccination, provide evidence-based tools to improve communication between providers
and parents, and compare 13-year-olds who have completed at least one HPV vaccination within
a University of Kentucky Adolescent Medicine Clinic before and after the intervention. There
were minimal differences in demographics of participants with improved attitudes following the
intervention. The study size was small and composed of all females. Demographic differences in
participants were not associated with attitude changes. Evidence suggests that medical providers
understand that there are multiple factors associated with HPV vaccine-hesitant parents, and that
there isn’t one effective delivery of parental education that is linked to increased HPV rates.
Research indicates that providers seek training in building effective communication skills with
parents. Evidence supports education models directed toward both health care providers and
parents to increase HPV vaccine completion (Widman et al., 2018; Eddens et al., 2017; Dilley et
al., 2018). This study did not provide direct parental intervention. However, the focus of the
evidence-based intervention was delivering tools to build connections and strengthen
communication between providers and parents, filling gaps represented in the literature. The
intervention provided by the HPV IQ toolkit delivered evidence-based techniques such as
motivational interviewing to medical staff and providers to improve HPV vaccination rates in the
Adolescent Medicine Clinic.
Evaluating clinic staff confidence and attitudes helps assess barriers of providers
recommending the HPV vaccination to adolescents. Provider attitudes, norms, self-efficacy and
intentions were evaluated in this study. The greatest change in pre and post surveys exhibited in
the study was the improvement of individual confidence of participants. The HPV IQ Toolkit’s
26

Announcement Approach improved medical provider and clinic staff’s self-efficacy.
Participants moved from somewhat agreeing before the QI session to strongly agreeing after the
QI session in their ability to influence change on a personal level to improve HPV vaccination
coverage. This improved provider efficacy was apparent across all participants, including
physicians, physician assistants, nurse practitioners, nurses, and medical assistants. Literature
reviewed prior to this project was limited to providers, although multi-disciplinary team sessions
with a larger sample size could be assessed in the future. The HPV IQ evidence-based toolkit
had limited role demographics within the evaluations. Future research may explore if evidencebased trainings, including multidisciplinary teams exhibit higher efficacy compared to training
limited to providers.
Evidence suggested that current training curricula lack adequate evaluation of programs.
In this study, participants were able to provide quantitative and qualitative feedback for the
improvement of the training program. Quantitative data observed that satisfaction of the training
was high. The qualitative suggestion presents an individual knowledge gap of the provider,
information on how specific education they would like to acquire, knowledge about parental
perception about data. Such input highlights the importance of evaluation practices that can
facilitate improvements of education to specific learning environments. During the QI session,
clinic medical providers and staff were encouraged that their team provided higher than average
adolescent vaccination rates even during the reduction of in-person activity due to COVID-19.
Data observed that UK Adolescent Medicine Clinic providers and staff had an overall positive
attitudes and self-efficacy. This may be a reflection of their population’s higher than average
completion rates as well as adolescent-specific population focus. Findings of this study could
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suggest that constructs with positive group means including attitudes, norms, self-efficacy, and
intentions of the HPV vaccination is associated with higher than average HPV vaccination rates.
Kentucky adolescents have lower than average rates of receiving at least one HPV
vaccination compared to others in the United States, but this was not apparent in the UK
Adolescent Medicine Clinic based on data collected from the Kentucky Immunization Registry.
Attitude assessment indicated that participants had a neutral attitude associated with their
perception of clinic HPV coverage.

Future pre-surveys could inquire whether medical

providers and clinic staff have a standard mechanism of obtaining and distributing CDC
recommended immunization data from their population. At this time, there is no standard
process for collecting and disseminating data on adolescent vaccination rates in the UK
Adolescent Medicine Clinic within their designated electronic medical record system.
Participants identified that setting goals and participating in improvement practices were
important components of the QI session. Standardizing the use of immunization information
systems can be a tool utilized to improve outcomes in clinics throughout Kentucky.
Implications
Literature has indicated that additional research needs to be conducted on how to improve
HPV immunization rates at multiple levels of intervention sites. Evidence has suggested that
providers seek the tools to discuss the multiple barriers associated with parental hesitation to
vaccinate their children with the HPV immunization. At the clinic level, the study showed that
the sample of participants had overall positive attitudes regarding HPV vaccination before the
quality improvement educational session, and the sample of adolescent patients with active
registries was already above the national averages. Following the intervention, there were
improvements in attitudes and vaccination rates of the HPV vaccination in both sets of samples.
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The study may be used to support future research that aims to evaluate clinic provider
and staff attitudes compared to a populations’ HPV vaccination rates. Further investigation is
needed to recommend whether a similar intervention would have a greater impact with lower
baseline attitudes and lower HPV initiation rates. Although the Adolescent Medicine Clinic
HPV initiation rates were higher than national averages, the state of Kentucky still has lower
than average rates of HPV initiation. A more thorough investigation into HPV vaccination rates
in Kentucky clinics should be obtained to locate clinics in need of education. Comprehensive
evaluation of training methods and their efficacy would help support medical providers’ need for
activities with lower-than-average clinic vaccination rates. Specific population, providers, and
community system needs must be assessed to address gaps to improve population health.
Developing process improvements can be strengthened through collaboration with
outside entities that have dedicated time and energy to developing practice tools. Publicly
available tools such as the HPV IQ Toolkit may be implemented to improve patient care across
multiple facilities. The utilization of state data registries may provide additional tools to
improve preventative practice outcomes without compromising vulnerable population’s data.
Centralized records could improve safety and practice efficacy in obtaining important medical
record data. Since 2020, the Kentucky Immunization Registry Data has published county-level
data on 68% of the state’s adolescent population. States such as Indiana require all facilities that
provide immunizations to report to the Indiana State Vaccination Registry. Disconnected data
and tracking practices create difficulty for health care facilities and families to have an
understanding of vaccination completion rates. The lack of policy mandates requiring
centralized recording of vaccination could be an area of focus in improving Kentucky’s HPV
vaccination rates. In the future, centralized registry systems could target facilities with poor
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HPV rates. Furthermore, individual clinics could use these centralized registry systems to
measure quality and set short and long-term practice goals.
Exploring this public health problem sheds light on the complexities of barriers that exist
in our healthcare system. The literature found that providers want to improve communication
and build on a fundamental connection in health care: the one between the provider and family
unit. This study recognizes the significance of not only our connection with the patient’s that
providers touch, but the relationships we have within our teams to build upon our strengths, and
the relationship we have with ourselves. The belief in the self is instrumental in creating
changes. Implementation of interventions at these seemly small levels have the ability to impact
an entire population’s outcome.
Limitations
This quasi-experimental study had several limitations threatening the study’s ability to
establish a causal association between the quality improvement intervention and the study’s
outcome. The study sample was limited by gender and ethnicity. This limited the ability to
evaluate whether gender and ethnicity impacted perceptions. The second limitation of the study
was a small sample from one setting with only 11 participants in the post-survey responses.
Collecting data from a variety of settings would minimize this limitation. The third limitation is
that this study was not randomized which threatens the study’s internal validity. Another
limitation included the scales used in this study. Limitations from the use of Likert scales
include the possibility of response bias, subjective interpretation, and choice restriction. As a
personal provider within the Adolescent Medicine team, there was a limitation associated with
my personal relationship with medical providers and staff within the clinic. Although, this could
be considered a strength of study considering participant’s perception of the trainer’s credibility.
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Conclusion
Evidence from the literature review suggests that multi-level strategies that are sensitive
to patient, provider, organization, and system need to aid in improving HPV completion rates
(Carhart et al., 2018). A gap exists between ACIP recommendations and HPV vaccination
completion due to multiple factors, including political, structural, and individual beliefs
surrounding the HPV vaccination. This study revealed that the University of Kentucky
Adolescent Medicine Clinic had higher than average rates of HPV vaccinations, and providers
and clinic staff had positive attitudes of the HPV vaccination. Following the quality
improvement session, there was a mean improvement in attitudes and 13-years-old males and
females one completed HPV vaccination dose. Statistically significant improvement was
observed in individual provider and staff self-efficacy in improving HPV rates. Further studies
could involve a larger and more diverse sample to improve validity and reduce limitations. Data
transparency of publically available tools and registries could facilitate more efficient quality
improvement efforts of community and state level improvement processes. This study observes
that quality improvement projects have the potential to empower individuals within a group. The
project exemplifies an individual clinic’s ability to obtain several tools necessary to set goals,
implement evidence-based practices, and improve patient outcomes.
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Table 1 – Demographic Data (N = 13)
Characteristic
Race
White, non-Hispanic
Black
Asian
Role
Registered Nurse
Clinical Service Technician
Nurse Practitioner
Physician
Physician’s Assistant
Years of experience
Less than 5
5-9
10-14
15-19
20 or greater
Sex
Female
Male

n (%)
11 (84.6%)
1 (7.7%)
1 (7.7%)
4 (30.8%)
2 (15.4%)
3 (23.1%)
3 (23.1%)
1 (7.7%)
5 (38.5%)
4 (30.8%)
2 (15.4%)
1 (7.7%)
1 (7.7%)
13 (100.0%)
0 (0.0%)
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Table 2 –Comparison of Pre and Post-Education Attitude about HPV vaccination (n=11)

Improving
HPV
vaccination
coverage is
an
important
goal for my
practice or
clinic
HPV
vaccination
coverage in
my
practice or
clinic is
lower than
I’d like it
to be
I feel
confident
in my
practice or
clinic can
improve
HPV
vaccination
coverage
I feel
confident
that I can
help
improve
HPV
vaccination
coverage in
my
practice or
clinic

Pre (n = 13 )
Mean (SD)

Post (n = 11 )
Mean (SD)

p

4.54 (1.2)

4.91 (.30)

2.85 (1.3)

2.27 (1.2)

4.62 (.65)

4.73 (.47)

1.00

4.08 (1.0)

4.80 (.42)

.025

.341

.395
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Table 3 – Paired T-Test Attitude Analysis
PrePostP
intervention intervention
Mean
mean
16.3

16.8

.529
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Table 4 – Evaluation of Quality Improvement Session (n = 11):
Evaluation of Quality Improvement Session
It was convenient
The facilitator was knowledgeable
It was understandable
It will help my clinic improve HPV coverage

39

Mean (SD)
4.82 (.41)
4.82 (.41)
4.82 (.41)
4.73 (.65)

Table 5 – Importance of QI Session Components
Importance of QI Session Components
Reviewing Coverage
Setting goals
Discussing Provider Recommendations
Committing to QI Strategies to Increase Vaccination Coverage
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Mean (SD)
4.36 (.81)
4.27 (.91)
4.82 (.41)
4.64 (.67)

Table 6 – Pre-test Participant Strategies
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Table 7 – Kentucky Immunization Registry Data of 13 Year Old Males and Females in
University of Kentucky Adolescent Medicine Clinic

One HPV Dose

Pre-intervention
11/9/2020
n(%)

Post-intervention
2/9/2021
n(%)

N = 127

N = 118

103 (81.1%)

102 (86.4%)

p

.26
No HPV Doses

24 (18.9%)

16 (13.6%)
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